共 48 条
- [42] Letter by Lawson et al Regarding Article, "Clinical Usefulness of PRECISE-DAPT Score for Predicting Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Analysis From the SMART-DATE Randomized Trial" CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (07)
- [43] Evaluating the learning curve in the prospective Randomized Clinical Trial of hemodynamic support with Impella 2.5 versus Intra-Aortic Balloon Pump in patients undergoing high-risk percutaneous coronary intervention: a prespecified subanalysis of the PROTECT II study AMERICAN HEART JOURNAL, 2014, 167 (04) : 472 - U85
- [44] Response by Choi et al to Letter Regarding Article, "Clinical Usefulness of PRECISE-DAPT Score for Predicting Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Analysis From the SMART-DATE Randomized Trial" CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (07)
- [45] Letter by Ando et al Regarding Article, "Risk of Acute Kidney Injury After Percutaneous Coronary Interventions Using Radial Versus Femoral Vascular Access: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium" CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (03) : 419 - 419
- [46] Letter by Ozeke et al Regarding Article, "Risk of Acute Kidney Injury After Percutaneous Coronary Interventions Using Radial Versus Femoral Vascular Access: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium" CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (03) : 420 - 420
- [47] Letter by Ye et al Regarding Article, "Early Use of N-Acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM Trial [N-Acetylcysteine in Acute Myocardial Infarction])" CIRCULATION, 2018, 137 (13) : 1422 - 1423
- [48] Letter by Mansour et al Regarding Article, "Early Use of N-Acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM Trial [N-Acetylcysteine in Acute Myocardial Infarction])" CIRCULATION, 2018, 137 (13) : 1420 - 1421